92% of healthcare organizations experienced a cyberattack in 2024

In the past 12 months, 92% of healthcare organizations reported experiencing at least one cyberattack, up from 88% in 2023, an Oct. 8 survey from Proofpoint and Ponemon Institute found.

Advertisement

Of those cyberattacks, 69% reported disruptions to patient care as a direct consequence.

Five things to know from the survey:

  1. The survey contains insights from 648 information technology and security practitioners in U.S. healthcare organizations. Proofpoint is a cybersecurity and compliance company and Ponemon Institute is a IT security research organization.
  2. Among organizations hit by the four most common types of cyberattacks — cloud compromise, ransomware, supply chain breaches and business email compromise — 56% reported poor patient outcomes due to delays in procedures and tests.  Additionally, 53% saw more medical complications, and 28% reported a rise in patient deaths, a 5% increase from last year.
  3. Supply chain attacks had the biggest impact on patient care, with 68% of respondents saying their organizations experienced such an attack.  Of those, 82% reported disruptions to patient care, up from 77% in 2023.
  4. Business email compromise was the top attack linked to poor outcomes from delayed procedures and tests, affecting 69% of organizations, followed by ransomware at 61%.
  5. Ransomware was also most likely to cause longer hospital stays (58%) and lead to more patients being diverted or transferred to other facilities (52%).

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Cybersecurity

Advertisement

Comments are closed.